Page last updated: 2024-09-03

bavachinin and Acute Myelogenous Leukemia

bavachinin has been researched along with Acute Myelogenous Leukemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Guo, F; Li, Y; Liu, J; Zhang, W1

Other Studies

1 other study(ies) available for bavachinin and Acute Myelogenous Leukemia

ArticleYear
A bavachinin analog, D36, induces cell death by targeting both autophagy and apoptosis pathway in acute myeloid leukemia cells.
    Cancer chemotherapy and pharmacology, 2022, Volume: 90, Issue:3

    Topics: Animals; Apoptosis; Autophagy; Cell Death; Cell Line, Tumor; Cell Proliferation; Flavones; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Mice

2022